Trial intelligence / Profile preview

Gemcitabine + ABI-007 in Metastatic Pancreatic Cancer

NCT00398086Phase 2Completed

Sponsor
Celgene Corporation
Start
Nov 2006
Primary completion
Sep 2008
Modality
Cytokines & Interferons, Fc-Fusion Proteins
Countries
1
01

Overview

A Phase 2 trial of Paclitaxel Micelles for Injection, sponsored by Celgene Corporation. Started Nov 2006; status: completed.

02

Drugs

Paclitaxel Micelles for Injection

Beyond the preview

Go deeper on NCT00398086.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00398086.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call